RALEIGH — Clinical trials software startup SignalPath is adding to its C-Suite.

Andy Corts has joined the Raleigh-based firm as senior vice president of Sponsor and CRO Solutions.

He brings over 20 years of healthcare IT strategy and execution expertise in the provider, payor, and life science industries.

Most recently, Corts served was the chief information officer at Sarah Cannon, the Cancer Institute of HCA Healthcare. He led the development of their clinical trial platform, personalized medicine and real world evidence offerings as well as their care management program.

“We are thrilled to have Andy join our executive team as we continue to develop innovative solutions that allow us to reimagine trial execution across our site and health system footprint,” said Dr. Brad Hirsch, CEO, SignalPath. “Andy is the ideal person to manage our growing engagement with sponsors and CROs who are interested in a spectrum of offerings from study design analytics to hybrid trials.”

Launched in 2017,  SignalPath is a startup focusing on technology to be used by its clients in clinical trials.

The company is supporting more than 2,500 clinical trials at some 250 sites and has 3,000 active users.

Raleigh clinical trials technology startup SignalPath raises $18M